COVID-19: a user's guide, status of the art, and an original proposal to terminate viral recurrence(256 views) Actis GC, Ribaldone DG, Fagoonee S, Pellicano R
Keywords: Covid-19 Complications Drug Therapy Epidemiology Therapy
, Carboxymethylcellulose Sodium Analogs, Derivatives Therapeutic Use
, Cytokine Release Syndrome Etiology
, Humans
, Immunization, Passive
, Interferon Inducers Therapeutic Use
, Mucocutaneous Lymph Node Syndrome Etiology
, Physical Distancing
, Poly I-C Therapeutic Use
, Polylysine Analogs, Practice Guidelines As Topic
, Double-Stranded Drug Effects
, Viral Drug Effects
, Recurrence
, Sars-Cov-2 Classification Genetics Pathogenicity
, Secondary Prevention,
Affiliations: *** IBB - CNR ***
Independent Academic Gastroenterologist, Turin General Hospitals, Turin, Italy - actis_g@libero.it.
Department of Medical Sciences, University of Turin, Turin, Italy.
Institute for Biostructure and Bioimaging, National Research Council, Molecular Biotechnology Center, Turin, Italy.
Unit of Gastroenterology, Molinette-SGAS Hospital, Turin, Italy.
References: Not available.
COVID-19: a user's guide, status of the art, and an original proposal to terminate viral recurrence
The world is now entering its 9th month of combat against a pandemic of deadly pneumonia. Started out from China in December 2019, the disease has been declared as caused by infection with a so far unknown RNA Coronavirus of the respiratory family, then named severe acute respiratory syndrome coronavirus (SARS)-CoV-2. In the absence of a vaccine, and with scientists still struggling for an effective therapy, COVID-19 (the SARS-dependent syndrome) carries up to now, a death toll of more than 590,000 (July 18,2020) undermining jobs and finance of contemporary society in all continents. Social distancing, the only measure hitherto shown to restrain virus spread, has been progressively loosened from May 2020 in some countries, leaving us in the fear of repeat attacks from the unchecked virus. We discuss the problem and propose to tentatively boost the anti-virus cell machinery by using lab-made viral mimics to engage cell receptors.
COVID-19: a user's guide, status of the art, and an original proposal to terminate viral recurrence
No results.
COVID-19: a user's guide, status of the art, and an original proposal to terminate viral recurrence